J9285 Injection, olaratumab, 10 milligrams
Also known as: olaratumab, Lartruvo
Injection of olaratumab, 10 milligram. A platelet-derived growth factor receptor alpha monoclonal antibody for soft tissue sarcoma.
In Plain Language
sarcoma cancer injection; soft tissue cancer treatment
Clinical Context
Used for advanced soft tissue sarcoma in combination with doxorubicin chemotherapy. Targets platelet-derived growth factor receptor alpha signaling.
RVU Information
CPT J9285 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9285?
CPT J9285 (Injection, olaratumab, 10 milligrams) is a J Codes (Drugs) code. Injection of olaratumab, 10 milligram. A platelet-derived growth factor receptor alpha monoclonal antibody for soft tissue sarcoma.
How is J9285 administered?
CPT J9285 is administered by a healthcare provider, typically via injection or infusion. Used for advanced soft tissue sarcoma in combination with doxorubicin chemotherapy. Targets platelet-derived growth factor receptor alpha signaling. It is used by Oncology, Surgery, Orthopedic Surgery.
When is CPT J9285 used?
Used for advanced soft tissue sarcoma in combination with doxorubicin chemotherapy. Targets platelet-derived growth factor receptor alpha signaling.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.